Innovation & intellectual property · 09/12/2025

EPO–EFPIA Annual Meeting 2025 to Discuss Quality, Legal Certainty, and Innovation in Biopharmaceutical Industry

The European Patent Office (EPO) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) held their annual meeting in 2025 to address key issues affecting the biopharmaceutical sector, including quality and legal certainty, as well as driving innovation in the industry.